Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Demand surges in Nigeria for new HIV prevention injection ahead of rollout | Africanews
Wealth Enhancement Advisory Services LLC Has $77.22 Million Stock Holdings in Gilead Sciences, Inc. $GILD
Nordea Investment Management AB Has $630.06 Million Stake in Gilead Sciences, Inc. $GILD
Henrickson Nauta Wealth Advisors Inc. Purchases 7,074 Shares of Gilead Sciences, Inc. $GILD - Markets Daily
Nordea Investment Management AB Increases Position in Gilead Sciences, Inc. $GILD - Stock Observer
IAM Advisory LLC Takes $1.27 Million Position in Gilead Sciences, Inc. $GILD
BCGM Wealth Management LLC Makes New Investment in Gilead Sciences, Inc. $GILD
Union Bancaire Privee UBP SA Grows Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Therapeutics Stocks Q4 Teardown: Moderna (NASDAQ:MRNA) Vs The Rest
Groupama Asset Managment Grows Stock Holdings in Gilead Sciences, Inc. $GILD
Anderson Hoagland & Co. Purchases New Stake in Gilead Sciences, Inc. $GILD
AIA Group Ltd Increases Stock Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by Wilmington Savings Fund Society FSB - Daily Political
GILD: HIV Franchise And Oncology Expansion Will Shape Bullish Long Term Outlook
Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care
Gilead Sciences, Inc. $GILD Shares Bought by Swiss Life Asset Management Ltd
Johanna Mercier Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - Markets Daily
Swiss Life Asset Management Ltd Purchases 31,807 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Sunbelt Securities Inc. Trims Holdings in Gilead Sciences, Inc. $GILD - Daily Political
A Look At Gilead Sciences (GILD) Valuation As Recent Returns Send Mixed Signals
Danske Bank A S Takes $133.05 Million Position in Gilead Sciences, Inc. $GILD
Captrust Financial Advisors Has $211.80 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead Sciences, Inc. $GILD Shares Purchased by Achmea Investment Management B.V.
Gilead Sciences, Inc. $GILD Holdings Cut by WBI Investments LLC - Daily Political
Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares
Gilead Sciences (NASDAQ:GILD) CFO Sells $432,690.00 in Stock
Fort Point Capital Partners LLC Sells 8,153 Shares of Gilead Sciences, Inc. $GILD
CSM Advisors LLC Sells 42,400 Shares of Gilead Sciences, Inc. $GILD
Bank of Nova Scotia Sells 319,843 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences Conference: 6-Month HIV Regimens, 12-Month PrEP, Livdelzi Expansion, Oncology Push - Stock Observer
Gilead Sciences at Barclays: CFO touts YEZTUGO launch, Arcellx deal and "long cycle" growth - Daily Political
2 Mega-Cap Nasdaq Stocks with Unusual Options Activity: What to Watch
Gilead Sciences, Inc. (NASDAQ:GILD) Short Interest Down 15.7% in February
Gilead Sciences, Inc. $GILD Shares Sold by Holocene Advisors LP - Daily Political
Crawford Investment Counsel Inc. Decreases Stock Position in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades
Calydon Capital Has $7.34 Million Position in Gilead Sciences, Inc. $GILD
BNP Paribas Has $7.71 Million Stake in Gilead Sciences, Inc. $GILD
Banco Bilbao Vizcaya Argentaria S.A. Grows Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Rating of "Moderate Buy" from Brokerages - Markets Daily
Ameriprise Financial Inc. Buys 400,002 Shares of Gilead Sciences, Inc. $GILD
Alliancebernstein L.P. Sells 258,213 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences (NASDAQ:GILD) Upgraded by Wall Street Zen to Strong-Buy Rating
BNP Paribas Sells 16,020 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Goldman Sachs Healthcare Stocks: Top 10 Stock Picks
Top Pharmaceutical Stocks To Watch Today - March 14th - Stock Observer
Dodge & Cox Trims Stock Position in Gilead Sciences, Inc. $GILD
Gilead Sciences (NASDAQ:GILD) Upgraded at Wall Street Zen
Harvest Fund Management Co. Ltd Has $10.34 Million Position in Gilead Sciences, Inc. $GILD - Stock Observer
Gilead Sciences, Inc. $GILD Shares Sold by Prudential PLC - Daily Political
Dodge & Cox Reduces Stock Position in Gilead Sciences, Inc. $GILD - Daily Political
EHP Funds Inc. Makes New Investment in Gilead Sciences, Inc. $GILD - Daily Political
Analysts Set Expectations for Gilead Sciences Q1 Earnings - Markets Daily
Martingale Asset Management L P Decreases Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Invesco Ltd. Purchases 1,618,453 Shares of Gilead Sciences, Inc. $GILD
Johnson Financial Group Inc. Lowers Stake in Gilead Sciences, Inc. $GILD - Daily Political
How Renewed Wall Street Optimism Around HIV, Oncology And IP Runway At Gilead Sciences (GILD) Has Changed Its Investment Story
Gilead Sciences Sees Unusually Large Options Volume (NASDAQ:GILD) - Daily Political
Investors Buy Large Volume of Gilead Sciences Call Options (NASDAQ:GILD) - Zolmax
Stock Traders Purchase Large Volume of Call Options on Gilead Sciences (NASDAQ:GILD)
Promising Pharmaceutical Stocks To Watch Now - March 12th - Stock Observer
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum And Mixed Fair Value Signals
Inceptionr LLC Takes Position in Gilead Sciences, Inc. $GILD - Markets Daily
Bokf Na Increases Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Bokf Na Raises Stock Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Stake Boosted by SageView Advisory Group LLC - Daily Political
Franklin Resources Inc. Decreases Stake in Gilead Sciences, Inc. $GILD - Daily Political
3 Top-Rated Stocks to Buy to Hedge Against Stagflation as Middle East Conflict Drags On
Mackenzie Financial Corp Lowers Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Magnetar Financial LLC Increases Stock Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by Mackenzie Financial Corp - Stock Observer
Gilead Sciences, Inc. (GILD) to Issue Quarterly Dividend of $0.82 on March 30th - Stock Observer
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
Jefferies Financial Group Begins Coverage on Gilead Sciences (NASDAQ:GILD) - Markets Daily
Gilead Sciences, Inc. $GILD Stock Position Decreased by Capital Research Global Investors
Gilead Sciences, Inc. $GILD Holdings Trimmed by Capital World Investors
Capital International Inc. CA Raises Stock Holdings in Gilead Sciences, Inc. $GILD
Gilead Sciences (NASDAQ:GILD) Now Covered by Analysts at Jefferies Financial Group - Stock Observer
Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from Analysts
Gilead to Acquire Arcellx, Inc. (ACLX) for Up to $7.8 billion
Banque Cantonale Vaudoise Has $8.91 Million Holdings in Gilead Sciences, Inc. $GILD
Is New HIV Switch Data Reframing the Investment Case for Gilead Sciences' Lenacapavir Platform (GILD)?
Grantham Mayo Van Otterloo & Co. LLC Acquires 68,006 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Gilead news
Latest news
Show moreZelenskyy Expresses Doubts About Budapest as Venue for Ukraine Peace Talks
Europe Rallies Behind Ukraine Amid Trump Pressure, Eyes Frozen Russian Assets
Gold Price Surge Fueled by Fed Rate Cut Expectations and Economic Uncertainty
